Antimicrobial activity of imipenem against isolates from complicated urinary tract infections

International Journal of Antimicrobial Agents

Volumn 19, Issue 6, 2002, Pages 565-569

  Ishihara, Satoshi ^a   Yamada, Toru ^a   Yokoi, Shigeaki ^a   Ito, Masayasu ^a   Yasuda, Mitsuru ^a   Nakano, Masahiro ^a   Kawada, Yukimichi ^a   Deguchi, Takashi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbapenems; Imipenem; Urinary tract infections; Uropathogens

Indexed keywords

ANTIINFECTIVE AGENT; IMIPENEM; METICILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; URINARY TRACT INFECTION; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONFERENCE PAPER; CONTROLLED STUDY; ENTEROCOCCUS AVIUM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; MEASUREMENT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS; ANTIBIOTICS, LACTAM; HUMAN;

EID: 0036021497     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00099-7     Document Type: Article

References (20)

1. Thienamycin: Development of imipenem-cilastatin
2. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria
3. Imipenem: First of a new class of β-lactam antibiotics
4. Antimicrobial activity of imipenem: The first thienamycin antibiotic
5. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections
6. The National Nosocomial Infections Surveillance System. Resistance to imipenem among selected gram-negative bacilli in the United States
7. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems
8. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase
9. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece
10. Clonal spread of imipenem-resistant Pseudomonas aeruginosa in the intensive care unit of a Turkish hospital
11. Efficacy and safety of imipenem/cilastatin: A review of worldwide clinical experience
12. Sensitivities to four carbapenems of bacteria isolated from patients with refractory complicated urinary tract infections and the detection of carbapenemase-producing Pseudomonas aeruginosa
13. Biochemical comparison of imipenem, meropenem and biapenem: Permeability, binding to penicillin-binding proteins, and stability to hydrolysis by β-lactamases
14. Decreases of susceptibility to low molecular weight β-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: Role of outer membrane protein D2 in their diffusion
15. Comparative evaluation of penicillin, ampicillin and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium
16. A study of the mechanisms involved in imipenem resistance in Pseudomonas aeruginosa isolates from Japan
17. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates
18. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients
19. A meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients
20. Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients